A Study of SHR-4375 in Subjects With Solid Tumors

NCT06764628 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

208

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: SHR-4375

Sponsor

Suzhou Suncadia Biopharmaceuticals Co., Ltd.